Figure 2.
Effect of HOCl on metal reducing power of RBC. (A) FRAP and potassium ferrocyanide assays (B) CUPRAC and phosphomolybdenum assays. These assays were done using hemolysates from control and HOCl-treated RBC. Except for 0.05 mM HOCl, all other results were significantly different for HOCl treated RBCs as compared to control.